ArticleJACC. Case reports2025
Cardiac Rehabilitation in Advanced Dilated Cardiomyopathy Within a Resource-Limited Setting.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exercise Participation and Rehabilitation in Cardiomyopathies: An Updated Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDilated cardiomyopathy (DCM) is a major cause of heart failure with reduced ejection fraction. Cardiac rehabilitation (CR) has been shown to improve functional capacity, but its use in advanced DCM remains limited. CASE SUMMARY: A 57-year-old man with idiopathic DCM and severe systolic dysfunction (left ventricular ejection fraction = 5%) presented with acute heart failure. Cardiac magnetic resonance revealed inferoseptal fibrosis and biventricular dilation. He was treated with optimal pharmacologic therapy and an 8-week supervised CR program. The 6-minute walk test improved by 114% (280-600 m), and heart rate recovery increased from 13 to 27 beats/min. DISCUSSION: This case highlights the positive impact of CR in advanced DCM, showing significant functional and metabolic improvements. Integrating CR into standard care is crucial for improving patient outcomes. TAKE-HOME MESSAGE: CR is safe and effective for patients with advanced DCM, which enhances prognosis and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.